A Randomized, Single-Dose, Double-Blind, Active-Controlled, Three-Way Crossover Study to Assess the Oral Bioavailability of Fermented Liposomal Multivitamin Supplementation in Healthy Volunteers. - Nil

Vidya Herbs Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年6月24日

试验速览

暂无简介。

•1. Subjects with Body mass index (BMI) of 18-25 kg/m2.
•2. Females of childbearing age, agree to use approved birth control methods during the study, and have negative urine pregnancy test (UPT) at screening.
•3. Subject understands the study procedures, is ready to comply and provide signed informed consent form (ICF) to participate in the study.

•1.Subjects who have consumed food rich in Vitamin A, D and B5, 2 days prior to screening.
•2.History of consumption medications known to interact with Multivitamin.
•3.Subjects having symptoms of viral infection.
•4.Pregnant or lactating women.
•5.History of
•Irritable bowel syndrome, malabsorption or gastrointestinal abnormalities which may affect drug absorption, duodenal ulcer or gastric ulcer, gastritis, Kidney disease, kidney stones, cardiac conditions, Recent blood donation (within 1 month) ,Current smoker or has quit smoking within last 3 months,Alcoholism and/or drug abuse, or heavy drinkers ,Immunodeficiency disease,Allergy, medication or supplement use that influences the immune system
•6.Subjects with known hypersensitivity to the investigational products.
•7.Subjects who have participated in any clinical trial in the past 1 month.
•8.Any subjects found to have entered into the study in violation of this protocol or if the subject is uncooperative during the study.
•9.Any other condition that in the opinion of the investigator that does not justify the subject’s participation in the trial.

发起方